LBA12_PRPERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): Cost effectiveness analysis results
Hulme, C; Hall, P; Shinkins, B; Chehadah, F; McCabe, C; Hiller, L; Dunn, J; Earl, H M
- 期刊名称Annals of Oncology
- 作者Hulme, C; Hall, P; Shinkins, B; Chehadah, F; McCabe, C; Hiller, L; Dunn, J; Earl, H M
- 卷第29卷
- 印刷ISSN0923-7534
- 电子ISSN1569-8041
- 文件大小99.76KB
- 发表时间2018-10-01
- DOI10.1093/annonc/mdy424.001